Faeth Therapeutics Statistics
Total Valuation
FTH has a market cap or net worth of $516.55 million. The enterprise value is $341.90 million.
| Market Cap | 516.55M |
| Enterprise Value | 341.90M |
Important Dates
The last earnings date was Tuesday, November 3, 2026, before market open.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FTH has 25.84 million shares outstanding. The number of shares has increased by 580.76% in one year.
| Current Share Class | 25.84M |
| Shares Outstanding | 25.84M |
| Shares Change (YoY) | +580.76% |
| Shares Change (QoQ) | +357.90% |
| Owned by Insiders (%) | 4.27% |
| Owned by Institutions (%) | 43.20% |
| Float | 18.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.21 |
| P/TBV Ratio | 3.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.12, with a Debt / Equity ratio of 0.00.
| Current Ratio | 16.12 |
| Quick Ratio | 15.84 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,596.81 |
Financial Efficiency
Return on equity (ROE) is -229.61% and return on invested capital (ROIC) is -55.76%.
| Return on Equity (ROE) | -229.61% |
| Return on Assets (ROA) | -50.29% |
| Return on Invested Capital (ROIC) | -55.76% |
| Return on Capital Employed (ROCE) | -49.49% |
| Weighted Average Cost of Capital (WACC) | 2.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$7.29M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +132.17% in the last 52 weeks. The beta is -0.29, so FTH's price volatility has been lower than the market average.
| Beta (5Y) | -0.29 |
| 52-Week Price Change | +132.17% |
| 50-Day Moving Average | 27.95 |
| 200-Day Moving Average | 25.28 |
| Relative Strength Index (RSI) | 40.78 |
| Average Volume (20 Days) | 367,995 |
Short Selling Information
The latest short interest is 2.32 million, so 8.98% of the outstanding shares have been sold short.
| Short Interest | 2.32M |
| Short Previous Month | 2.07M |
| Short % of Shares Out | 8.98% |
| Short % of Float | 12.54% |
| Short Ratio (days to cover) | 5.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -83.10M |
| Pretax Income | -211.36M |
| Net Income | -211.36M |
| EBITDA | -82.99M |
| EBIT | -83.10M |
| Earnings Per Share (EPS) | -$24.64 |
Balance Sheet
The company has $174.80 million in cash and $145,000 in debt, with a net cash position of $174.65 million or $6.76 per share.
| Cash & Cash Equivalents | 174.80M |
| Total Debt | 145,000 |
| Net Cash | 174.65M |
| Net Cash Per Share | $6.76 |
| Equity (Book Value) | 161.10M |
| Book Value Per Share | 6.23 |
| Working Capital | 166.81M |
Cash Flow
In the last 12 months, operating cash flow was -$43.27 million and capital expenditures -$9,000, giving a free cash flow of -$43.28 million.
| Operating Cash Flow | -43.27M |
| Capital Expenditures | -9,000 |
| Depreciation & Amortization | 106,000 |
| Net Borrowing | -193,000 |
| Free Cash Flow | -43.28M |
| FCF Per Share | -$1.67 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -580.76% |
| Shareholder Yield | -580.76% |
| Earnings Yield | -123.28% |
| FCF Yield | -8.38% |
Analyst Forecast
The average price target for FTH is $55.31, which is 176.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $55.31 |
| Price Target Difference | 176.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 17, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |